| Safety and efficacy of NVX-CoV2373 Covid-19 vaccine PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... New England Journal of Medicine 385 (13), 1172-1183, 2021 | 975 | 2021 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 681 | 2021 |
| Social media and pharmacovigilance: a review of the opportunities and challenges R Sloane, O Osanlou, D Lewis, D Bollegala, S Maskell, M Pirmohamed British journal of clinical pharmacology 80 (4), 910-920, 2015 | 166 | 2015 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 140 | 2022 |
| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 138 | 2022 |
| Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of … X Liu, APS Munro, S Feng, L Janani, PK Aley, G Babbage, D Baxter, ... Journal of Infection 84 (6), 795-813, 2022 | 60 | 2022 |
| Pharmacogenetics of adverse drug reactions O Osanlou, M Pirmohamed, AK Daly Advances in Pharmacology 83, 155-190, 2018 | 57 | 2018 |
| Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... Clinical Infectious Diseases 76 (3), 398-407, 2023 | 34 | 2023 |
| Efficacy of the NVX-CoV2373 Covid-19 vaccine against the B. 1.1. 7 variant PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... MedRxiv, 2021.05. 13.21256639, 2021 | 22 | 2021 |
| Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial X Liu, APS Munro, A Wright, S Feng, L Janani, PK Aley, G Babbage, ... Journal of Infection 87 (1), 18-26, 2023 | 11 | 2023 |
| Adenovirus Type 7 causing severe lower respiratory tract infection in immunocompetent adults: a comparison of two contrasting cases from an intensive care unit in North West … T Wingfield, L Dearden, P Calvert, O Osanlou, B Johnston, A Chawla, ... Clinical infection in practice 2, 100007, 2019 | 6 | 2019 |
| The millennial doctor–A blue collar worker? O Osanlou, R Hull Future Hospital Journal 4 (1), 45, 2017 | 3 | 2017 |
| The use of technical simulation training in surgical education in the United Kingdom E Snashall, O Osanlou, S Hindocha Open Medicine Journal 3 (1), 2016 | 2 | 2016 |
| Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B. 1.1. 7 Variant S Toback, PT Heath, EP Galiza, D Baxter, M Boffito, D Browne, F Burns, ... | 1 | 2021 |
| Core medical training, not core medical service provision O Osanlou, F Frost, R Shaw, C Watters, K Clark Future Healthcare Journal 4 (Suppl 2), s29, 2017 | 1 | 2017 |
| 14 hours to see the consultant… tick… tock O Osanlou, C Watters, R Bhattacharjee, P Calvert, N Jones, Y Khan, ... Future Healthcare Journal 4 (Suppl 2), s22, 2017 | 1 | 2017 |
| Internet based communication in healthcare A Osanlou, RA Earnshaw, PS Excell, R Osanlou, O Osanlou, E Osanlou 2015 Internet Technologies and Applications (ITA), 251-255, 2015 | 1 | 2015 |
| Challenges and Opportunities for Internet Based Healthcare utilizing Social Media R Osanlou, O Osanlou, A Osanlou, E Osanlou, RA Earnshaw, PS Excell, ... Proceedings of Internet Technologies and Applications (1TA), Retrieved from …, 2015 | 1 | 2015 |
| 60 Reducing the maternal deaths and learning leadership: can Sri Lanka learn from the UK experience? K Parimelalagapillai, O Osanlou, N Lyons, G Kandiah, MDA Krishanth, ... BMJ Leader 8 (Suppl 1), 2024 | | 2024 |
| The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight O Bird, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, DR Chadwick, ... Epidemiology and Infection 152, 2024 | | 2024 |
